2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Keratosis, Actinic
22
Cholangiocarcinoma
8
Carcinoma, Basal Cell
8
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
6
Skin Neoplasms
4
Bile Duct Neoplasms
4
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lung Neoplasms
3
Liver Neoplasms
3
Leukoplakia, Oral
3
Colorectal Neoplasms
3
Warts
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Pleural Diseases
2
Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Squamous Cell
2
Bowen's Disease
2
Basal Cell Nevus Syndrome
2
Barrett Esophagus
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Interventions
Pemetrexed
40
Cisplatin
35
pembrolizumab
21
Nivolumab
17
Carboplatin
16
Ipilimumab
13
Gemcitabine
10
Cyclophosphamide
9
fludarabine
6
durvalumab
6
Bevacizumab
6
Radiotherapy, Intensity-Modulated
4
LMB-100
4
Drug Therapy
4
Dexamethasone
4
tremelimumab
3
tazemetostat
3
spartalizumab
3
olaparib
3
niraparib
3
atezolizumab
3
anetumab ravtansine
3
amatuximab
3
Vinorelbine
3
Paclitaxel
3
Oxaliplatin
3
Imatinib Mesylate
3
Fluorouracil
3
Cerebral Decortication
3
Blood Specimen Collection
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma
×
Photochemotherapy
×
Clear all
NCT02662504
2026-02-05
MesoPDT
University Hospital, Lille
Phase 2
Completed
6 enrolled